Crawford Investment Counsel Inc Astrazeneca PLC Transaction History

Crawford Investment Counsel Inc

  • $5.7 Billion
  • Q3 2024

A detailed history of Crawford Investment Counsel Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 1,536,033 shares of AZN stock, worth $102 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
1,536,033
Previous 1,545,904 0.64%
Holding current value
$102 Million
Previous $121 Million 0.73%
% of portfolio
2.1%
Previous 2.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$76.67 - $87.62 $756,809 - $864,897
-9,871 Reduced 0.64%
1,536,033 $120 Million
Q2 2024

Aug 14, 2024
SELL
$66.81 - $80.83 $730,433 - $883,714
-10,933 Reduced 0.7%
1,545,904 $121 Million
Q1 2024

May 15, 2024
BUY
$61.03 - $69.57 $2.9 Million - $3.31 Million
47,597 Added 3.15%
1,556,837 $105 Million
Q4 2023

Feb 14, 2024
SELL
$61.89 - $69.28 $896,786 - $1 Million
-14,490 Reduced 0.95%
1,509,240 $102 Million
Q3 2023

Nov 14, 2023
BUY
$64.85 - $71.7 $1.11 Million - $1.23 Million
17,142 Added 1.14%
1,523,730 $103 Million
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $3.13 Million - $3.39 Million
-44,728 Reduced 2.88%
1,506,588 $108 Million
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $4.03 Million - $4.57 Million
-63,857 Reduced 3.95%
1,551,316 $108 Million
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $722,348 - $938,613
-13,325 Reduced 0.82%
1,615,173 $110 Million
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $882,623 - $2.26 Million
-16,647 Reduced 1.01%
1,628,498 $89.3 Million
Q2 2022

Aug 15, 2022
SELL
$59.26 - $71.14 $5.74 Million - $6.89 Million
-96,915 Reduced 5.56%
1,645,145 $109 Million
Q1 2022

May 16, 2022
SELL
$55.72 - $67.12 $2.56 Million - $3.08 Million
-45,941 Reduced 2.57%
1,742,060 $116 Million
Q4 2021

Feb 07, 2022
BUY
$54.02 - $63.83 $290,303 - $343,022
5,374 Added 0.3%
1,788,001 $104 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $218,573 - $239,147
3,934 Added 0.22%
1,782,627 $107 Million
Q2 2021

Aug 16, 2021
SELL
$48.42 - $60.18 $5.46 Million - $6.78 Million
-112,705 Reduced 5.96%
1,778,693 $107 Million
Q1 2021

May 14, 2021
BUY
$47.16 - $54.44 $3.71 Million - $4.29 Million
78,748 Added 4.34%
1,891,398 $94 Million
Q4 2020

Feb 01, 2021
SELL
$48.52 - $58.02 $607,470 - $726,410
-12,520 Reduced 0.69%
1,812,650 $90.6 Million
Q3 2020

Oct 29, 2020
BUY
$53.07 - $61.1 $357,691 - $411,814
6,740 Added 0.37%
1,825,170 $100 Million
Q2 2020

Aug 13, 2020
SELL
$43.1 - $55.31 $3.81 Million - $4.88 Million
-88,288 Reduced 4.63%
1,818,430 $96.2 Million
Q1 2020

May 15, 2020
BUY
$37.79 - $51.33 $2.97 Million - $4.03 Million
78,497 Added 4.29%
1,906,718 $85.2 Million
Q4 2019

Feb 14, 2020
BUY
$42.46 - $50.46 $9.21 Million - $10.9 Million
216,926 Added 13.46%
1,828,221 $91.2 Million
Q3 2019

Nov 12, 2019
SELL
$40.12 - $45.47 $449,584 - $509,536
-11,206 Reduced 0.69%
1,611,295 $71.8 Million
Q2 2019

Aug 12, 2019
SELL
$37.28 - $41.68 $799,805 - $894,202
-21,454 Reduced 1.31%
1,622,501 $67 Million
Q1 2019

May 09, 2019
SELL
$35.49 - $43.02 $567,875 - $688,363
-16,001 Reduced 0.96%
1,643,955 $66.5 Million
Q4 2018

Feb 14, 2019
SELL
$36.86 - $41.49 $3.06 Million - $3.45 Million
-83,035 Reduced 4.76%
1,659,956 $63 Million
Q3 2018

Nov 09, 2018
BUY
$34.76 - $39.72 $574,339 - $656,293
16,523 Added 0.96%
1,742,991 $69 Million
Q2 2018

Aug 14, 2018
BUY
$34.55 - $37.05 $3.82 Million - $4.09 Million
110,487 Added 6.84%
1,726,468 $60.6 Million
Q1 2018

May 15, 2018
BUY
$32.97 - $36.63 $33.4 Million - $37.1 Million
1,014,119 Added 168.5%
1,615,981 $56.5 Million
Q4 2017

Feb 13, 2018
BUY
$32.09 - $34.78 $327,606 - $355,069
10,209 Added 1.73%
601,862 $20.9 Million
Q3 2017

Nov 14, 2017
BUY
$28.96 - $34.0 $17.1 Million - $20.1 Million
591,653
591,653 $20 Million

Others Institutions Holding AZN

# of Institutions
1,360
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Crawford Investment Counsel Inc Portfolio

Follow Crawford Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email